… Liver metastases develop in 40–50% of patients with … and provide cure when liver metastases
can be totally resected with … surgical resection of colorectal metastases varies from 25% …

… Chemotherapy-associated liver injury is a major cause for concern when treating patients
with colorectal liver metastases. … pathological effect of specific chemotherapy regimens on the …

… use of chemotherapy for colorectal liver metastases has raised … of perioperative chemotherapy
for colorectal liver metastases, … patterns of liver injury, and strategies to treat patients with …

… chemotherapy on liver histology in 102 patients undergoing their first liver resection for
colorectal liver metastases. … the use of chemotherapy and the different types of liver damage with …

… for patients with resectable colorectal liver metastases (CRLM), but the benefits of using
systemic chemotherapy for these patients … Although systemic chemotherapy is likely to improve …

… factor for patients with metastatic breast cancer. Liver metastases are generally considered
to be less responsive to chemotherapy than metastases in other sites, and patients with …

… Surgical resection remains the standard treatment for patients with resectable colorectal
liver metastases (CLM) and is the only single-modality therapy associated with cure. Five-year …

… Typically, this is a late finding, when metastases are already … liver metastases is not common
in patients with MBC. Of all … Patients with liver metastases plus metastases at other sites …

… group of patients with unresectable liver metastases, there … neo-adjuvant chemotherapy
or portal vein embolisation. For … chemotherapy after resection of colorectal liver metastases. …

… However, the impact of these agents on the liver … chemotherapy-induced hepatic injury and
assesses their impact on outcomes following hepatic resection for colorectal liver metastases …